FDA forces Lunesta dosage drop over dozing fears | PharmaBoardroom

FDA forces Lunesta dosage drop over dozing fears

face
TAGS: ,

The FDA is making another move to ensure the safety of sleep drugs, and this time the target is Lunesta, requiring maker Sunovion to change the drug's label and lower the recommended starting dose.

Latest Report